Solder Materials Market

Publisher Grand View Research

Published Jan 29, 2026

Length 107 Pages

SKU # GV20873303

Description

Solder Materials Market Summary

The global solder materials market size was estimated at USD 4.97 billion in 2025 and is projected to reach USD 6.91 billion by 2033, growing at a CAGR of 4.2% from 2026 to 2033. Demand for solder materials is increasing as the electronics manufacturing industry rapidly expands across consumer electronics, automotive electronics, and industrial equipment.

The rising adoption of smartphones, wearables, and smart home devices has significantly increased the volume of printed circuit boards (PCBs), thereby driving solder consumption. Growth in electric vehicles and advanced driver-assistance systems (ADAS) has further amplified demand, as these systems require reliable and high-performance soldering solutions. In addition, miniaturization of electronic components has increased the need for high-precision solder materials. Expansion of data centers and 5G infrastructure has also supported consistent demand growth. Medical electronics and industrial automation applications are emerging as additional drivers of demand.

Key demand drivers include technological advancements in electronics, increasing PCB assembly volumes, and the transition toward lead-free solder materials. Automotive electrification and rising semiconductor content per vehicle have significantly increased solder usage. Growth in renewable energy systems, such as solar inverters and energy storage electronics, also contributes to demand. Increasing investments in electronics manufacturing across the Asia Pacific and North America have strengthened market growth. Stringent reliability requirements in aerospace, defense, and medical devices have further increased demand for high-quality solder alloys. Rising automation in electronics manufacturing is supporting consistent solder paste and wire consumption.

The solder materials industry is witnessing strong innovation in lead-free solder alloys, low-temperature soldering solutions, and high-reliability materials for advanced electronics. Development of solder materials compatible with fine-pitch and miniaturized components is a key trend. Manufacturers are focusing on improving thermal fatigue resistance and electrical conductivity to meet demanding application requirements. Growth in no-clean and halogen-free solder pastes is gaining traction due to environmental and performance advantages. Automation-friendly solder materials designed for high-speed assembly lines are becoming more common. R&D efforts are also focused on improving joint reliability in harsh environments. These innovations are shaping the next generation of solder materials.

Global Solder Materials Market Report Segmentation

This report forecasts revenue growth at regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global solder materials market report based on the product, end-use, and region:

Product Outlook (Revenue, USD Billion, 2021 - 2033)
Solder Wire
Solder Paste
Solder Bar
Solder Powder
Others
End-use Outlook (Revenue, USD Billion, 2021 - 2033)
Automotive
Industrial Equipment
Electronics
Telecommunications
Others
Regional Outlook (Revenue, USD Billion, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Asia Pacific
China
Japan
India
Latin America
Middle East and Africa

Please note The report will be delivered in 2-3 business days upon order notification.

Chapter 1. Latent Tuberculosis Infection Detection Market: Methodology and Scope: 1.1. Market Segmentation and Scope; 1.1.1. Segment Definitions; 1.1.1.1. Product Method; 1.1.1.2. Test Segment; 1.1.1.3. Application Segment; 1.1.1.4. End Use Segment; 1.2. Regional Scope; 1.3. Estimates and Forecast Timeline; 1.4. Objectives; 1.4.1. Objective - 1; 1.4.2. Objective - 2; 1.4.3. Objective - 3; 1.5. Research Methodology; 1.6. Information Procurement; 1.6.1. Purchased Database; 1.6.2. GVR’s Internal Database; 1.6.3. Secondary Sources; 1.6.4. Primary Research; 1.7. Information or Data Analysis; 1.7.1. Data Analysis Models; 1.8. Market Formulation & Validation; 1.9. Model Details; 1.9.1. Commodity Flow Analysis; 1.10. List of Secondary Sources; 1.11. List of Abbreviations
Chapter 2. Latent Tuberculosis Infection Detection Market: Executive Summary: 2.1. Market Snapshot; 2.2. Brand Snapshot; 2.3. Test Snapshot; 2.4. End Use Snapshot; 2.5. Application Snapshot; 2.6. Competitive Landscape Snapshot
Chapter 3. Latent Tuberculosis Infection Detection Market Variables, Trends, & Scope: 3.1. Market Segmentation and Scope; 3.2. Market Lineage Outlook; 3.2.1. Parent Market Outlook; 3.2.2. Related/Ancillary Market Outlook; 3.3. Market Dynamics; 3.4. Market Drivers Analysis; 3.4.1. Increasing risk of developing active tuberculosis infection from LTBI; 3.4.2. Increasing funding programs to promote TB diagnosis; 3.4.3. Favorable government initiatives for combating TB; 3.4.4. Surge in geriatric population; 3.5. Market Restraint Analysis; 3.5.1. Presence of stringent rules and regulations pertaining to diagnosis; 3.6. Porter’s Five Forces Analysis; 3.7. PESTLE Analysis; 3.8. Pipeline Analysis
Chapter 4. Latent Tuberculosis Infection Detection Market: Brand Estimates & Trend Analysis: 4.1. Global Latent Tuberculosis Infection Detection Market: Brand Dashboard; 4.2. Global Latent Tuberculosis Infection Detection Market: Brand Movement Analysis; 4.3. Global Latent Tuberculosis Infection Detection Market by brand, Revenue; 4.4. QFT-Plus (QuantiFERON-TB Gold Plus); 4.4.1. QFT-Plus (QuantiFERON-TB Gold Plus) market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 4.5. Others; 4.5.1. Others market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands)
Chapter 5. Latent Tuberculosis Infection Detection Market: Test Estimates & Trend Analysis: 5.1. Global Latent Tuberculosis Infection Detection Market: Test Dashboard; 5.2. Global Latent Tuberculosis Infection Detection Market: Test Movement Analysis; 5.3. Global Latent Tuberculosis Infection Detection Market by Test, Revenue; 5.4. Tuberculin Skin Test (TST); 5.4.1. Tuberculin Skin Test (TST) market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 5.5. Interferon Gamma Released Assay (IGRA); 5.5.1. Interferon Gamma Released Assay (IGRA) market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands)
Chapter 6. Latent Tuberculosis Infection Detection Market: Application Estimates & Trend Analysis: 6.1. Global Latent Tuberculosis Infection Detection Market: Application Dashboard; 6.2. Global Latent Tuberculosis Infection Detection Market: Application Movement Analysis; 6.3. Global Latent Tuberculosis Infection Detection Market by Application, Revenue; 6.4. Household Contacts with Pulmonary TB; 6.4.1. Household contacts with pulmonary TB market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 6.5. PLHIV; 6.5.1. PLHIV market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 6.6. Others; 6.6.1. Others market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands)
Chapter 7. Latent Tuberculosis Infection Detection Market: End Use Estimates & Trend Analysis: 7.1. Global Latent Tuberculosis Infection Detection Market: End Use Dashboard; 7.2. Global Latent Tuberculosis Infection Detection Market: End Use Movement Analysis; 7.3. Global Latent Tuberculosis Infection Detection Market by End Use, Revenue; 7.4. Diagnostic Laboratories; 7.4.1. Diagnostic laboratories market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 7.5. Hospitals/Clinics; 7.5.1. Hospitals/Clinics market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 7.6. Academic & Research Institutions; 7.6.1. Academic & research institutions market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands)
Chapter 8. Latent Tuberculosis Infection Detection Market: Regional Estimates & Trend Analysis by Product Type, Technology, and End Use: 8.1. Regional Dashboard; 8.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:; 8.3. North America; 8.3.1. U.S.; 8.3.1.1. Key country dynamics; 8.3.1.2. Regulatory framework/ reimbursement structure; 8.3.1.3. Competitive scenario; 8.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.3.2. Canada; 8.3.2.1. Key country dynamics; 8.3.2.2. Regulatory framework/ reimbursement structure; 8.3.2.3. Competitive scenario; 8.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.3.3. Mexico; 8.3.3.1. Key country dynamics; 8.3.3.2. Regulatory framework/ reimbursement structure; 8.3.3.3. Competitive scenario; 8.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.4. Europe; 8.4.1. UK; 8.4.1.1. Key country dynamics; 8.4.1.2. Regulatory framework/ reimbursement structure; 8.4.1.3. Competitive scenario; 8.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.4.2. Germany; 8.4.2.1. Key country dynamics; 8.4.2.2. Regulatory framework/ reimbursement structure; 8.4.2.3. Competitive scenario; 8.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.4.3. France; 8.4.3.1. Key country dynamics; 8.4.3.2. Regulatory framework/ reimbursement structure; 8.4.3.3. Competitive scenario; 8.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.4.4. Italy; 8.4.4.1. Key country dynamics; 8.4.4.2. Regulatory framework/ reimbursement structure; 8.4.4.3. Competitive scenario; 8.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.4.5. Spain; 8.4.5.1. Key country dynamics; 8.4.5.2. Regulatory framework/ reimbursement structure; 8.4.5.3. Competitive scenario; 8.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.4.6. Norway; 8.4.6.1. Key country dynamics; 8.4.6.2. Regulatory framework/ reimbursement structure; 8.4.6.3. Competitive scenario; 8.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.4.7. Sweden; 8.4.7.1. Key country dynamics; 8.4.7.2. Regulatory framework/ reimbursement structure; 8.4.7.3. Competitive scenario; 8.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.4.8. Denmark; 8.4.8.1. Key country dynamics; 8.4.8.2. Regulatory framework/ reimbursement structure; 8.4.8.3. Competitive scenario; 8.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.4.9. Netherlands; 8.4.9.1. Key country dynamics; 8.4.9.2. Regulatory framework/ reimbursement structure; 8.4.9.3. Competitive scenario; 8.4.9.4. Netherlands market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.4.10. Belgium; 8.4.10.1. Key country dynamics; 8.4.10.2. Regulatory framework/ reimbursement structure; 8.4.10.3. Competitive scenario; 8.4.10.4. Belgium market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.4.11. Finland; 8.4.11.1. Key country dynamics; 8.4.11.2. Regulatory framework/ reimbursement structure; 8.4.11.3. Competitive scenario; 8.4.11.4. Finland market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.4.12. Luxembourg; 8.4.12.1. Key country dynamics; 8.4.12.2. Regulatory framework/ reimbursement structure; 8.4.12.3. Competitive scenario; 8.4.12.4. Luxembourg market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.4.13. Iceland; 8.4.13.1. Key country dynamics; 8.4.13.2. Regulatory framework/ reimbursement structure; 8.4.13.3. Competitive scenario; 8.4.13.4. Iceland market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.5. Asia Pacific; 8.5.1. Japan; 8.5.1.1. Key country dynamics; 8.5.1.2. Regulatory framework/ reimbursement structure; 8.5.1.3. Competitive scenario; 8.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.5.2. China; 8.5.2.1. Key country dynamics; 8.5.2.2. Regulatory framework/ reimbursement structure; 8.5.2.3. Competitive scenario; 8.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.5.3. India; 8.5.3.1. Key country dynamics; 8.5.3.2. Regulatory framework/ reimbursement structure; 8.5.3.3. Competitive scenario; 8.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.5.4. Australia; 8.5.4.1. Key country dynamics; 8.5.4.2. Regulatory framework/ reimbursement structure; 8.5.4.3. Competitive scenario; 8.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.5.5. South Korea; 8.5.5.1. Key country dynamics; 8.5.5.2. Regulatory framework/ reimbursement structure; 8.5.5.3. Competitive scenario; 8.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.5.6. Thailand; 8.5.6.1. Key country dynamics; 8.5.6.2. Regulatory framework/ reimbursement structure; 8.5.6.3. Competitive scenario; 8.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.5.7. Singapore; 8.5.7.1. Key country dynamics; 8.5.7.2. Regulatory framework/ reimbursement structure; 8.5.7.3. Competitive scenario; 8.5.7.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.5.8. Bangladesh; 8.5.8.1. Key country dynamics; 8.5.8.2. Regulatory framework/ reimbursement structure; 8.5.8.3. Competitive scenario; 8.5.8.4. Bangladesh market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.6. Latin America; 8.6.1. Brazil; 8.6.1.1. Key country dynamics; 8.6.1.2. Regulatory framework/ reimbursement structure; 8.6.1.3. Competitive scenario; 8.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.6.2. Argentina; 8.6.2.1. Key country dynamics; 8.6.2.2. Regulatory framework/ reimbursement structure; 8.6.2.3. Competitive scenario; 8.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.7. MEA; 8.7.1. South Africa; 8.7.1.1. Key country dynamics; 8.7.1.2. Regulatory framework/ reimbursement structure; 8.7.1.3. Competitive scenario; 8.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.7.2. Saudi Arabia; 8.7.2.1. Key country dynamics; 8.7.2.2. Regulatory framework/ reimbursement structure; 8.7.2.3. Competitive scenario; 8.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.7.3. UAE; 8.7.3.1. Key country dynamics; 8.7.3.2. Regulatory framework/ reimbursement structure; 8.7.3.3. Competitive scenario; 8.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands); 8.7.4. Kuwait; 8.7.4.1. Key country dynamics; 8.7.4.2. Regulatory framework/ reimbursement structure; 8.7.4.3. Competitive scenario; 8.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million, Volume, in thousands)
Chapter 9. Competitive Landscape: 9.1. Recent Developments & Impact Analysis, By Key Market Participants; 9.2. Company/Competition Categorization; 9.3. Vendor Landscape; 9.3.1. List of key distributors and channel partners; 9.3.2. Key customers; 9.3.3. Key company market share analysis, 2025; 9.3.4. QIAGEN; 9.3.4.1. Company overview; 9.3.4.2. Financial performance; 9.3.4.3. Product benchmarking; 9.3.4.4. Strategic initiatives; 9.3.5. BIOMÉRIEUX; 9.3.5.1. Company overview; 9.3.5.2. Financial performance; 9.3.5.3. Product benchmarking; 9.3.5.4. Strategic initiatives; 9.3.6. Oxford Immunotec; 9.3.6.1. Company overview; 9.3.6.2. Financial performance; 9.3.6.3. Product benchmarking; 9.3.6.4. Strategic initiatives; 9.3.7. SD Biosensor, INC.; 9.3.7.1. Company overview; 9.3.7.2. Financial performance; 9.3.7.3. Product benchmarking; 9.3.7.4. Strategic initiatives; 9.3.8. Wantai BioPharm; 9.3.8.1. Company overview; 9.3.8.2. Financial performance; 9.3.8.3. Product benchmarking; 9.3.8.4. Strategic initiatives; 9.3.9. Lionex GmbH; 9.3.9.1. Company overview; 9.3.9.2. Financial performance; 9.3.9.3. Product benchmarking; 9.3.9.4. Strategic initiatives; 9.3.10. Sanofi; 9.3.10.1. Company overview; 9.3.10.2. Financial performance; 9.3.10.3. Product benchmarking; 9.3.10.4. Strategic initiatives; 9.3.11. Serum Institute of India Pvt. Ltd; 9.3.11.1. Company overview; 9.3.11.2. Financial performance; 9.3.11.3. Product benchmarking; 9.3.11.4. Strategic initiatives; 9.3.12. ARKRAY, Inc.; 9.3.12.1. Company overview; 9.3.12.2. Financial performance; 9.3.12.3. Product benchmarking; 9.3.12.4. Strategic initiatives; 9.3.13. Par Pharmaceutical, Inc.; 9.3.13.1. Company overview; 9.3.13.2. Financial performance; 9.3.13.3. Product benchmarking; 9.3.13.4. Strategic initiatives

Pricing

Currency Rates

Single User Email from Publisher $5,950
Multi User License Fulfilled by Publisher $6,950
Global Site License Email from Publisher $8,950

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now